Langmann et al. [67] found that epigenetic modifications within the ATP-binding cassette transporter A1 (ABCA1) gene promoter contributed to the interindividual variability in plasma HDL cholesterol levels in FH patients. The gene discussed is ABCA1; the disease is familial hyperaldosteronism.